Palogic Value Management, L.P. 23and Me Holding Co. Transaction History
Palogic Value Management, L.P.
- $236 Billion
- Q2 2024
A detailed history of Palogic Value Management, L.P. transactions in 23and Me Holding Co. stock. As of the latest transaction made, Palogic Value Management, L.P. holds 120,000 shares of ME stock, worth $40,800. This represents 0.02% of its overall portfolio holdings.
Number of Shares
120,000Holding current value
$40,800% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ME
# of Institutions
159Shares Held
100MCall Options Held
270KPut Options Held
349K-
New View Capital Partners I, LLC Burlingame, CA19.5MShares$6.61 Million18.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$5.24 Million0.0% of portfolio
-
Euclidean Capital LLC New York, NY10.2MShares$3.48 Million0.5% of portfolio
-
Sapphire Ventures, L.L.C. Austin, TX5.29MShares$1.8 Million1.76% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.94MShares$1.68 Million0.0% of portfolio
About 23andMe Holding Co.
- Ticker ME
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 259,768,000
- Market Cap $88.3M
- Description
- 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...